Roche Corleen M. 4
4 · Immunome Inc. · Filed Jun 1, 2021
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Roche Corleen M.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-05-28+16,609→ 16,609 totalExercise: $20.92Exp: 2031-05-28→ Common Stock (16,609 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on May 28, 2022, and one-thirty-sixth (1/36th) of the remaining shares subject to the option shall vest every month thereafter.